... (PTV), and to analyze the resultant doses of 3-dimensional conformal radiotherapy (3D-CRT) to critical organs. Methods: 15 patients with unresectable extrahepatic cholangiocarcinoma (EHCC) were enrolled into this study. PTV CT -based plans were initially made, and then PTV PET-CT -based plans were...

... was resected and pathologically proven to be a small cell carcinoma. The patient was given adjuvant radiotherapy but refused any chemotherapy. At the 12-month follow-up the patient was alive and well. Conclusion: Primary intracranial small cell carcinoma presenting as an isolated lesion is extremely rare...

... alternative in medically inoperable patients. Method: Between June 2007 and December 2010, 65 patients with NSCLC were treated with image-guided hypofractionated radiotherapy. The Union Internationale Contre le Cancer (UICC) stage distribution was: IA, n = 19; IB, n = 15; IIB, n = 5; IIIA, n = 10; IIIB, n = 6...

...Sandra Nuyts; Alysa Fairchild Technical improvements in computed tomography and magnetic resonance imaging as well as the wider availability of biological imaging have facilitated the implementation of high-precision 3-dimensional conformal and intensity-modulated radiotherapy (RT) in head and neck...

.... Radiotherapy Lung cancer Radiation pneumonitis Erlotinib Case Report · Kasuistik Onkologie 2012;35:191 194 DOI: 10.1159/000337616 Published online: March 15, 2012 Radiation Recall Pneumonitis Caused by Erlotinib after Palliative Definitive Radiotherapy Cem Onala Huseyin Abalib Zafer Kocc Sibel Karad...

... in this article. The possible consequences of chemotherapy and radiotherapy on the course of pregnancy and the health of the offspring, as well as the interactions between cancer and pregnancy, are reviewed with the focus on childhood cancer, malignant lymphomas, and breast cancer. Despite chemo- or radiotherapy...

...Renata Soumarová; Viktor Maňásek; Hana Perková; Ivan Ferák; Ivan Ferák Background: Primary epididymal carcinoma is an extremely rare disease with a bad prognosis. We describe the first report of radiotherapy for definitive treatment of such a tumour. Case Report: A 35-year-old man with a tumour...

... seen between 1960 and 2009. Median age at diagnosis was 37 years (range: 20–72), with a median follow-up of 22.7 years (range: 1–48). All patients but 12 were treated with adjuvant radiotherapy. Acute toxicity was mainly gastrointestinal, with 7.6% classified as grade 2. The 10-year disease-specific...

...Pierluigi Brugnaro; Erika Morelli; Marta Fiscon; Francesca Ebo; Giorgio Rosini; Fabio Belussi; Franklyn Eseme; Carlo A. Mione; Pietro M. Donisi; Enzo Raise Chemotherapy HIV infection Merkel cell carcinoma Radiotherapy 23 3 2011 2011 Copyright / Drug Dosage / Disclaimer...

... initiated a Rare Cancer Network (RCN) study. Materials and Methods: Six member institutions of the RCN collected clinical data on 31 patients. Treatment consisted of definitive radiotherapy in 14 patients and radical prostatectomy in 16 patients. One patient was treated with androgen deprivation alone...

...Abhishek Pandey; Joern Beier; Laura Dobkowicz; Simone Wolf; Hansjörg Keller Background: Late urological complications after radiotherapy of a primary tumor in the pelvis are rare but challenging. We report a case of extensive bladder necrosis with hydronephrosis and sepsis nearly 45 years after...

..., if this agents are combined with irradiation. Material and Method: We report about a 53-year-old patient presenting with an advanced non-small-cell lung cancer. Systemical treatment with IFN-alpha and 13-cis retinoic acid was performed concurrently with radiotherapy. The patient’s follow-up, response...

...W. Schmidt; M. Altmannsberger; S. Steiner Background : In patients with nonresectable non-small cell lung cancer (NSCLC) only receiving best supportive care, the individual survival time varies as widely as in those patients actively treated with chemo- and radiotherapy. Therefore, factors which...

...). In stage III (Sézary’s syndrome) photo-pheresis is a well-tolerated first-line therapy which can be supported by interferon-a, methotrexate or retinoids. In case of disease progression, systemic chemotherapy is reasonable (prednisone and chlorambucil or, if resistant, CHOP). Alternatives are radiotherapy...

... (BrdUrd). Short Tpot values may identify patients who would be expected to benefit from acceler-ated-fractionation radiotherapy regimens. This paper reviews the literature to date on Tpot. It shows large variations in values even for tumors of similar histologies, indicating a rapid proliferation rate...

...-functioning and disease-free bladder. Bladder preservation in muscle invasive cancer is only possible in a selected group of patients by transurethral resection, partial cystectomy or definitive radiotherapy. The introduction of effective systemic chemotherapy made integrated therapy strategies attractive...

... was time- and concentration-dependent, with a maximum at a 72-hour incubation. Treatment of the cells with estrogen (ES) increased their radiosensitivity at very high ES doses only. Conclusion: For patients treated with radiotherapy and TMX simultaneously, a negative effect can not be excluded. 12 5...

.... Prostatic carcinoma Radiotherapy Stage Dl prostatic cancer ORIGINALARBEIT ORIGINAL ARTICLE Onkologie 1994:17:586-593 T Wiegel M. Bresselb R. Schmidt a Abteilung Strahlenthcrapie, Universitäts­ krankenhaus Hamburg-Eppendorf bAbteilung Urologie. Allgemeines Kranken­ haus Hamburg-Harburg Stage D1...

... previously reported the decline rate of PSA levels in patients with cancer of the prostate during radiotherapy; however, on the basis of a small number of patients, no definite conclusions were drawn. Material and Methods : In this report, we update our findings from a prospective study in which changes...

...M.J. Eble; E. Lohr; M. Wannenmacher Background : It has been shown that the response on radiotherapy in human tumors is correlated to the oxygen supply. Polarographic needle electrodes offer a feasible tool to determine the oxygen tension distribution in human tumors. The peroral administration...